CKD-Associated Pruritus
Open Access
- 13 February 2026
- journal article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (7) , 1658-1661
Abstract
No abstract availableFunding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (1K23DK140642)
- National Institute of Diabetes and Digestive and Kidney Diseases (1K23DK140642)
This publication has 9 references indexed in Scilit:
- Association of Chronic Kidney Disease–Associated Pruritus With the Sleep Disturbance, Depression, Pain, Anxiety, and Low Energy/Fatigue Symptom Cluster: A Retrospective Cohort StudyKidney Medicine, 2025
- Patient-Reported Symptoms Compared With Nephrologist Documentation During Outpatient Visits: A Retrospective Patient-Reported Outcome Measures StudyKidney Medicine, 2025
- The Pathogenesis of CKD–Associated Pruritus: A Theoretical Model and Relevance for TreatmentKidney360, 2024
- Pruritus in Hemodialysis Patients: Longitudinal Associations With Clinical and Patient-Reported OutcomesAmerican Journal of Kidney Diseases, 2023
- Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 StudiesKidney Medicine, 2022
- Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysisPLOS Medicine, 2022
- Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritusJournal of Patient-Reported Outcomes, 2021
- A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusNew England Journal of Medicine, 2020
- A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patientsJournal of Dermatological Treatment, 2009